Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis

被引：0
|
作者：
Maxwell J. Lasko
Holly K. Huse
David P. Nicolau
Joseph L. Kuti
机构：
[1] Hartford Hospital,Center for Anti
[2] Huntington Hospital,Infective Research and Development
[3] Hartford Hospital,Department of Clinical Microbiology
[4] Harbor-UCLA Medical Center,Division of Infectious Diseases
来源：
Annals of Clinical Microbiology and Antimicrobials | / 20卷
关键词：
Antibiotic resistance; Broth microdilution; Ceftazidime–avibactam; Ceftolozane–tazobactam;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis
    Lasko, Maxwell J.
    Huse, Holly K.
    Nicolau, David P.
    Kuti, Joseph L.
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2021, 20 (01)
  • [2] Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis
    Taccetti, G.
    Campana, S.
    Neri, A. S.
    Boni, V.
    Festini, F.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) : 166 - 169
  • [3] ANTIBIOTIC SUSCEPTIBILITY PATTERNS OF STRAINS OF PSEUDOMONAS-AERUGINOSA FROM PATIENTS WITH CYSTIC-FIBROSIS
    OJEDAVARGAS, MM
    BAQUERO, F
    MONZONMORENO, C
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 314 - 315
  • [4] ACTIVITY OF ANTIBIOTIC COMBINATIONS AGAINST VIRULENT PSEUDOMONAS - AERUGINOSA FROM CYSTIC-FIBROSIS PATIENTS
    LIEBERMAN, RA
    KLEINHENZ, AJ
    HAWLEY, HB
    CLINICAL RESEARCH, 1985, 33 (04): : A931 - A931
  • [5] Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients
    Nazik, Hasan
    Ongen, Betigul
    Erturan, Zayre
    Salcioglu, Melek
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2007, 60 (2-3) : 82 - 86
  • [6] In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients
    VanDevanter, Donald R.
    Van Dalfsen, Jill M.
    Burns, Jane L.
    Mayer-Hamblett, Nicole
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2015, 4 (02) : 151 - 154
  • [7] The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages
    Essoh, Christiane
    Blouin, Yann
    Loukou, Guillaume
    Cablanmian, Arsher
    Lathro, Serge
    Kutter, Elizabeth
    Hoang Vu Thien
    Vergnaud, Gilles
    Pourcel, Christine
    PLOS ONE, 2013, 8 (04):
  • [8] Susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients to ciprofloxacin
    Bauernfeind, A
    Jungwirth, R
    Ratjen, F
    DRUGS, 1999, 58 (Suppl 2) : 209 - 210
  • [9] Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients to Ciprofloxacin
    A. Bauernfeind
    R. Jungwirth
    F. Ratjen
    Drugs, 1999, 58 : 209 - 210
  • [10] SYNERGY WITH GLATIRAMER ACETATE REDUCES TOBRAMYCIN MINIMUM INHIBITORY CONCENTRATIONS AGAINST PSEUDOMONAS AERUGINOSA FROM CYSTIC FIBROSIS AIRWAYS
    Murphy, R. A.
    Thrane, S.
    Schelenz, S.
    Harrison, J.
    Vorup-Jensen, T.
    Davies, J. C.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S154 - S155
12345